MarkArthur Does it look to anyone out there, there may be significant synergy for NOK, HPQ, and MSFT as a result of the Windows 8 OS/platform?
9/19/12
Reply
(2)
•!Report Abuse
View all 2 replies
Abrane: Advertisment hasn't really hit yet. Once they start to hit the media circles then we should see some excitment buys to have sticks jump.
9/19/12
•!Report Abuse
Abrane: Im sure all of Windows 8.. Surface, Lumia, Desktop will launch at the same time with adverts
9/19/12
•!Report Abuse
The Scientist Solid OS data for THLD Th-302 in panc ca. OS+2.5 mos in highest dose. Tarceva approved with 0.4 mos. Discontinuation rate lowest for highest
9/17/12
Reply
(2)
•!Report Abuse
View all 2 replies
The Scientist: TH-302 dose. High prob FDA approval. Huge unmet need. Gemzar initial approval based on 126 pts (Gemzar insert). Adcetris approv 102/58 pts
9/17/12
•!Report Abuse
The Scientist: Huge improvement PFS/OS over current SOC. Good safety profile-fewer discontinuations with highest dose.
9/17/12
•!Report Abuse
The Scientist THLDCEO at Stifel Nicolaus presentation stated OS data for ESMO abstract 9/17 will be 'subtlety different' than mature data on 9/29
9/13/12
Reply
•!Report Abuse
View all 0 replies
LATEST REPLIES
BornIn87 NOK is working with Mozilla. I don't know about you guys, but that excites me. The firefox OS is a great idea.
MarkArthur Does it look to anyone out there, there may be significant synergy for NOK, HPQ, and MSFT as a result of the Windows 8 OS/platform?
9/19/12
Reply
(2)
•!Report Abuse
View all 2 replies
Abrane: Advertisment hasn't really hit yet. Once they start to hit the media circles then we should see some excitment buys to have sticks jump.
9/19/12
•!Report Abuse
Abrane: Im sure all of Windows 8.. Surface, Lumia, Desktop will launch at the same time with adverts
9/19/12
•!Report Abuse
The Scientist Solid OS data for THLD Th-302 in panc ca. OS+2.5 mos in highest dose. Tarceva approved with 0.4 mos. Discontinuation rate lowest for highest
9/17/12
Reply
(2)
•!Report Abuse
View all 2 replies
The Scientist: TH-302 dose. High prob FDA approval. Huge unmet need. Gemzar initial approval based on 126 pts (Gemzar insert). Adcetris approv 102/58 pts
9/17/12
•!Report Abuse
The Scientist: Huge improvement PFS/OS over current SOC. Good safety profile-fewer discontinuations with highest dose.
9/17/12
•!Report Abuse
Daniel Lauchheimer Zuck's interview yesterday good and bad. Good = expanding into search. Bad = not building own phone or OS. FB now doesn't control destiny
9/12/12
Reply
(1)
•!Report Abuse
View all 1 replies
realornot: Good, because he listens to his wife. Bad, because he listens to his wife. LOL
9/12/12
•!Report Abuse
The Scientist THLD Th-302 OS panc CA data likely to b > Abraxane OS. Abrax trial began 3/09. Near end of trial on 9/11, protocol changed and added 210 pts
8/7/12
Reply
(3)
•!Report Abuse
View all 3 replies
The Scientist: Th-302 targets hypoxic niche, which should also kill CSCs.
8/7/12
•!Report Abuse
Noreika: OT- That was a bummer yesterday that Bapi got cancelled. I really thought the Apo4 non-carriers would have some positive news.
8/8/12
•!Report Abuse
The Scientist Awaiting CELG Abraxane data on panc CA. SPARC hypothesis controversial. Abrax does not improve OS in breast CA, which is usually SPARC+.
7/31/12
Reply
(2)
•!Report Abuse
View all 2 replies
The Scientist: Perhaps destroying SPARC/stroma promotes metastasis - allows for easier malignant cell escape. Abrax should have worked better in breast CA.
7/31/12
•!Report Abuse
Noreika: Off topic: Did ILNS.PK get halted today? I can't wait to see the Study 301 results!! (the non-carrier one) Or was it the Study 300?
7/31/12
•!Report Abuse
The Scientist Bar for THLD TH-302 in pancreatic CA extremely low. Tarceva, approved for panc CA, PFS +0.3 mos, OS +0.4 mos! Cannot get much lower
6/7/12
Reply
(3)
•!Report Abuse
View all 3 replies
The Scientist: It is quite amazing that the FDA approved a $50K/yr tx for a 12 day survival benefit. Large pharma sure knows how to work the system
6/8/12
•!Report Abuse
Maria Auziliadora: I really hope they aprrove it my dad died from Pancreatic cancer!!!
6/26/12
•!Report Abuse
Gene Chan BBRY prediction: PlayBook unit sales spectacularly exceeds analysts' expectations due to a successful discount promotion and OS 2.0.
3/23/12
Reply
(5)
•!Report Abuse
View all 5 replies
gustavitt: Agreed, PlayBook sales should be way above street expectations. Handsets will most likely fall within expectations, which would be positive.
3/26/12
•!Report Abuse
BadCop_NoDonuts: sounds like some Blackberry flavored koolaid..:-)
3/27/12
•!Report Abuse
Canary Cash I wonder if AAPL will ever license OSX to anyone? Would it be a good hedge against recessionary pressures?
11/24/11
Reply
(3)
•!Report Abuse
View all 3 replies
Canary Cash: Indeed, but what if AAPL wanted to sweep in a vast swath of PCRFY.OB Market Share money, they would only need license it to DELL/HPQ
11/24/11
•!Report Abuse
mP1: Clones would add more issues because of the wider range of h/w to support. Most of windows hangs are bad drivers.